| dc.creator | Toumanidou V., Dastiridou A., Kourtis N., Androudi S. | en |
| dc.date.accessioned | 2023-01-31T10:09:16Z | |
| dc.date.available | 2023-01-31T10:09:16Z | |
| dc.date.issued | 2019 | |
| dc.identifier | 10.1080/09273948.2017.1409357 | |
| dc.identifier.issn | 09273948 | |
| dc.identifier.uri | http://hdl.handle.net/11615/79744 | |
| dc.description.abstract | Purpose: To report an unusual case of Bartonella henselae neuroretinitis (BHNR) in a patient with myelinated retinal nerve fibers (MRNFs). Methods: A 56-year-old male presented for a consultation, because of a decrease in visual acuity from his right eye. Onset was unclear and the patient was not sure if this was a new symptom. Results: Fundoscopy revealed MRNF without any other clinical findings. After 2 weeks, the patient returned complaining of further visual acuity decrease. Fundoscopy disclosed macular star formation. The patient was treated with azithromycin. The visual acuity deteriorated to 20/400 and we added systemic corticosteroids with slight improvement of the visual fields but minimal visual gain to 20/160. Serology test results were positive for BH (IgG titers>1/256). Conclusions: Co-existence of BHNR and MRNF can create diagnostic dilemmas. The presence of myelinated nerve sheath in combination with the expected swelling in neuroretinitis may have caused an irreversible mechanical nerve damage. © 2019, © 2019 Taylor & Francis Group, LLC. | en |
| dc.language.iso | en | en |
| dc.source | Ocular Immunology and Inflammation | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85039549496&doi=10.1080%2f09273948.2017.1409357&partnerID=40&md5=db893c64ccbec980c978928ab9858d84 | |
| dc.subject | antibiotic agent | en |
| dc.subject | azithromycin | en |
| dc.subject | corticosteroid | en |
| dc.subject | immunoglobulin G antibody | en |
| dc.subject | antiinfective agent | en |
| dc.subject | adult | en |
| dc.subject | antibiotic therapy | en |
| dc.subject | antibody titer | en |
| dc.subject | Bartonella henselae | en |
| dc.subject | best corrected visual acuity | en |
| dc.subject | case report | en |
| dc.subject | cat scratch disease | en |
| dc.subject | clinical article | en |
| dc.subject | consultation | en |
| dc.subject | corticosteroid therapy | en |
| dc.subject | human | en |
| dc.subject | Letter | en |
| dc.subject | male | en |
| dc.subject | middle aged | en |
| dc.subject | myelinated nerve | en |
| dc.subject | neuroretinitis | en |
| dc.subject | nonhuman | en |
| dc.subject | onset age | en |
| dc.subject | ophthalmoscopy | en |
| dc.subject | optic nerve atrophy | en |
| dc.subject | retina exudate | en |
| dc.subject | retina macula lutea | en |
| dc.subject | retinal nerve fiber layer | en |
| dc.subject | retinitis | en |
| dc.subject | serology | en |
| dc.subject | subretinal fluid | en |
| dc.subject | systemic therapy | en |
| dc.subject | visual field | en |
| dc.subject | visual field defect | en |
| dc.subject | bacterial eye infection | en |
| dc.subject | cat scratch disease | en |
| dc.subject | complication | en |
| dc.subject | isolation and purification | en |
| dc.subject | nerve fiber | en |
| dc.subject | pathology | en |
| dc.subject | retina ganglion cell | en |
| dc.subject | retinitis | en |
| dc.subject | visual acuity | en |
| dc.subject | Anti-Bacterial Agents | en |
| dc.subject | Bartonella henselae | en |
| dc.subject | Cat-Scratch Disease | en |
| dc.subject | Eye Infections, Bacterial | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Nerve Fibers | en |
| dc.subject | Ophthalmoscopy | en |
| dc.subject | Retinal Ganglion Cells | en |
| dc.subject | Retinitis | en |
| dc.subject | Visual Acuity | en |
| dc.subject | Taylor and Francis Ltd | en |
| dc.title | Neuroretinitis Secondary to Bartonella Henselae in a Patient with Myelinated Retinal Nerve Fibers: Diagnostic Dilemmas and Treatment | en |
| dc.type | other | en |